Clinical Relevance of Alerts from a Decision Support System, PHARAO, for Drug Safety Assessment in the Older Adults

Overview

Journal BMC Geriatr

Publisher Biomed Central

Specialty Geriatrics

Date 2019 Jun 13

PMID 31185943

Citations 7

Authors

Khedidja Hedna

Marine L Andersson

Hanna Gyllensten

Staffan Hagg

Ylva Bottiger

Affiliations

Soon will be listed here.

Abstract

Background: PHARAO is a decision support system developed to evaluate the risk for a set of either common or serious side-effects resulting from a combination of pharmacodynamic effects from a patient's medications. The objective of this study was to investigate the validity of the risk scores for the common side-effects generated by PHARAO in older patients.

Methods: Side-effects included were sedation, constipation, orthostatic symptoms, anticholinergic and serotonergic effects. The alerts generated by PHARAO were tested in 745 persons ≥65 years old. Dispensed prescriptions retrieved from the Swedish prescribed drug register were used to generate the pharmacological risk scores of patients' medications. Symptoms possibly related to side-effects were extracted from medical records data.

Results: The PHARAO system generated 776 alerts, most often for the risk of anticholinergic symptoms. The total specificity estimates of the PHARAO system were 0.95, 0.89 and 0.78 for high, intermediate and low risk alerts, respectively. The corresponding sensitivity estimates were between 0.12 and 0.37. The negative predictive value was 0.90 and the positive predictive value ranged between 0.20-0.25.

Conclusions: The PHARAO system had a high specificity and negative predictive value to detect symptoms possibly associated with the of patients' medications, while the sensitivity and positive predictive value were low. The PHARAO system has the potential to minimise the risk of over-alerts in combination with a drug-drug interaction alert system, but should be used in connection with a medical evaluation of the patient.

Citing Articles

Potential Adverse Drug Events Identified with Decision Support Algorithms from Janusmed Risk Profile-A Retrospective Population-Based Study in a Swedish Region.

Hammar T, Jonsen E, Bjorneld O, Askfors Y, Andersson M, Lincke A Pharmacy (Basel). 2024; 12(6).

PMID: 39585094 PMC: 11587405. DOI: 10.3390/pharmacy12060168.

Development and retrospective evaluation of a clinical decision support system for the efficient detection of drug-related problems by clinical pharmacists.

Skalafouris C, Blanc A, Grosgurin O, Marti C, Samer C, Lovis C Int J Clin Pharm. 2022; 45(2):406-413.

PMID: 36515779 PMC: 10147748. DOI: 10.1007/s11096-022-01505-5.

Potential Drug Interactions in Adults Living in Manaus: A Real-World Comparison of Two Databases, 2019.

Menezes Almeida Biase T, Brunieri G, Silva M, Galvao T Turk J Pharm Sci. 2022; 19(5):543-551.

PMID: 36317874 PMC: 9634440. DOI: 10.4274/tjps.galenos.2021.96603.

Clinical validation of clinical decision support systems for medication review: A scoping review.

Damoiseaux-Volman B, Medlock S, van der Meulen D, de Boer J, Romijn J, Van der Velde N Br J Clin Pharmacol. 2021; 88(5):2035-2051.

PMID: 34837238 PMC: 9299995. DOI: 10.1111/bcp.15160.

The Influence of Pharmacogenetics on the Clinical Relevance of Pharmacokinetic Drug-Drug Interactions: Drug-Gene, Drug-Gene-Gene and Drug-Drug-Gene Interactions.

Hahn M, Roll S Pharmaceuticals (Basel). 2021; 14(5).

PMID: 34065361 PMC: 8160673. DOI: 10.3390/ph14050487.

References

Moxey A, Robertson J, Newby D, Hains I, Williamson M, Pearson S . Computerized clinical decision support for prescribing: provision does not guarantee uptake. J Am Med Inform Assoc. 2010; 17(1):25-33. PMC: 2995634. DOI: 10.1197/jamia.M3170. View

Wirehn A, Karlsson H, Carstensen J . Estimating disease prevalence using a population-based administrative healthcare database. Scand J Public Health. 2007; 35(4):424-31. DOI: 10.1080/14034940701195230. View

Frank C . Recognition and treatment of serotonin syndrome. Can Fam Physician. 2008; 54(7):988-92. PMC: 2464814. View

Roshanov P, Fernandes N, Wilczynski J, Hemens B, You J, Handler S . Features of effective computerised clinical decision support systems: meta-regression of 162 randomised trials. BMJ. 2013; 346:f657. DOI: 10.1136/bmj.f657. View

Mintzer J, Burns A . Anticholinergic side-effects of drugs in elderly people. J R Soc Med. 2000; 93(9):457-62. PMC: 1298101. DOI: 10.1177/014107680009300903. View

Pirmohamed M, James S, Meakin S, Green C, Scott A, Walley T . Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ. 2004; 329(7456):15-9. PMC: 443443. DOI: 10.1136/bmj.329.7456.15. View

van der Sijs H, Mulder A, van Gelder T, Aarts J, Berg M, Vulto A . Drug safety alert generation and overriding in a large Dutch university medical centre. Pharmacoepidemiol Drug Saf. 2009; 18(10):941-7. DOI: 10.1002/pds.1800. View

Saverno K, Hines L, Warholak T, Grizzle A, Babits L, Clark C . Ability of pharmacy clinical decision-support software to alert users about clinically important drug-drug interactions. J Am Med Inform Assoc. 2010; 18(1):32-7. PMC: 3005877. DOI: 10.1136/jamia.2010.007609. View

Gandhi T, Burstin H, Cook E, Puopolo A, Haas J, Brennan T . Drug complications in outpatients. J Gen Intern Med. 2000; 15(3):149-54. PMC: 1495358. DOI: 10.1046/j.1525-1497.2000.04199.x. View

10.

Bottiger Y, Laine K, Korhonen T, Lahdesmaki J, Shemeikka T, Julander M . Development and pilot testing of PHARAO-a decision support system for pharmacological risk assessment in the elderly. Eur J Clin Pharmacol. 2017; 74(3):365-371. PMC: 5808089. DOI: 10.1007/s00228-017-2391-3. View

11.

Wettermark B, Hammar N, Fored C, MichaelFored C, Leimanis A, Olausson P . The new Swedish Prescribed Drug Register--opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf. 2006; 16(7):726-35. DOI: 10.1002/pds.1294. View

12.

Wolfstadt J, Gurwitz J, Field T, Lee M, Kalkar S, Wu W . The effect of computerized physician order entry with clinical decision support on the rates of adverse drug events: a systematic review. J Gen Intern Med. 2008; 23(4):451-8. PMC: 2359507. DOI: 10.1007/s11606-008-0504-5. View

13.

Rosas-Carrasco O, Garcia-Pena C, Sanchez-Garcia S, Vargas-Alarcon G, Gutierrez-Robledo L, Juarez-Cedillo T . The relationship between potential drug-drug interactions and mortality rate of elderly hospitalized patients. Rev Invest Clin. 2013; 63(6):564-73. View

14.

Dunkley E, Isbister G, Sibbritt D, Dawson A, Whyte I . The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity. QJM. 2003; 96(9):635-42. DOI: 10.1093/qjmed/hcg109. View

15.

Ludvigsson J, Otterblad-Olausson P, Pettersson B, Ekbom A . The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research. Eur J Epidemiol. 2009; 24(11):659-67. PMC: 2773709. DOI: 10.1007/s10654-009-9350-y. View

16.

Rochon P, Gurwitz J . Optimising drug treatment for elderly people: the prescribing cascade. BMJ. 1997; 315(7115):1096-9. PMC: 2127690. DOI: 10.1136/bmj.315.7115.1096. View

17.

Robertson J, Walkom E, Pearson S, Hains I, Williamsone M, Newby D . The impact of pharmacy computerised clinical decision support on prescribing, clinical and patient outcomes: a systematic review of the literature. Int J Pharm Pract. 2010; 18(2):69-87. View

18.

Maher R, Hanlon J, Hajjar E . Clinical consequences of polypharmacy in elderly. Expert Opin Drug Saf. 2013; 13(1):57-65. PMC: 3864987. DOI: 10.1517/14740338.2013.827660. View

19.

Hakkarainen K, Gyllensten H, Jonsson A, Sundell K, Petzold M, Hagg S . Prevalence, nature and potential preventability of adverse drug events - a population-based medical record study of 4970 adults. Br J Clin Pharmacol. 2013; 78(1):170-83. PMC: 4168391. DOI: 10.1111/bcp.12314. View

20.

Coleman J, van der Sijs H, Haefeli W, Slight S, McDowell S, Seidling H . On the alert: future priorities for alerts in clinical decision support for computerized physician order entry identified from a European workshop. BMC Med Inform Decis Mak. 2013; 13:111. PMC: 3850158. DOI: 10.1186/1472-6947-13-111. View